Clinical trial

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

NCT06750185

Drugs and interventions used in this trial

10 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BIOLOGICAL · Unmapped registry intervention BNT317 DL1 Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention BNT317 DL2 Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention BNT317 DL3 Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention BNT317 DL4 Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention BNT317 DL5 Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention BNT317 DL6 Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention BNT317 selected DLA Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention BNT317 selected DLB Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention SoC chemotherapy 1 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention SoC chemotherapy 2 Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE1, PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-01-13

PhasePHASE1 / PHASE2

Conditions

Advanced Solid Tumorunresolved

Interventions

BNT317 DL1BIOLOGICAL

BNT317 DL2BIOLOGICAL

BNT317 DL3BIOLOGICAL

BNT317 DL4BIOLOGICAL

BNT317 DL5BIOLOGICAL

BNT317 DL6BIOLOGICAL

BNT317 selected DLABIOLOGICAL

BNT317 selected DLBBIOLOGICAL

SoC chemotherapy 1DRUG

SoC chemotherapy 2DRUG

Sponsors & collaborators

BioNTech SElead sponsor

Mapped research locations

DallasTexas, United States1 San AntonioTexas, United States1 CharlestonSouth Carolina, United States1 LouisvilleKentucky, United States1 Grand RapidsMichigan, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06750185 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.